These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5925076)

  • 41. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 42. The use and abuse of vasodilator drugs.
    Rose SS
    Vasc Dis; 1967 Apr; 4(2):67-82. PubMed ID: 6027150
    [No Abstract]   [Full Text] [Related]  

  • 43. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries.
    Schlüssel H
    Angiologica; 1966; 3(6):370-6. PubMed ID: 5958239
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 46. [Conservative therapy of arterial occlusive diseases on a rational basis].
    Alexander K
    Dtsch Med J; 1972 May; 23(5):343-8. PubMed ID: 5036945
    [No Abstract]   [Full Text] [Related]  

  • 47. [Can the Doppler method indicate the usefulness of vasodilator therapy?].
    Bartolo M; Antignani PL
    Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of Tebonin in peripheral arterial circulatory disorders].
    Franke G; Maxis M
    Med Monatsschr; 1969 Mar; 23(3):128-30. PubMed ID: 5779072
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
    Risse S
    Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
    [No Abstract]   [Full Text] [Related]  

  • 50. Vascular insufficiency and Heberden's nodes. A possible etiologic factor.
    Hunter W
    J S C Med Assoc; 1967 May; 63(5):165-9. PubMed ID: 5233029
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 52. Paniverine of a new type for the management of obliterative arterial diseases.
    Bugár-Mészáros K; Fonó J
    Ther Hung; 1965; 13(4):151-5. PubMed ID: 5864163
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapeutic control of the path of the blood flow of the end organs].
    Gersmeyer EF; Leicht E
    Med Welt; 1967 Feb; 8():426-31. PubMed ID: 6044562
    [No Abstract]   [Full Text] [Related]  

  • 54. [New chemical substances for therapeutic use].
    Clin Ter; 1970 Mar; 52(6):571-4. PubMed ID: 5452999
    [No Abstract]   [Full Text] [Related]  

  • 55. Fenofibrate and losartan.
    Daskalopoulou SS; Mikhailidis DP; Athyros VG; Papageorgiou AA; Elisaf M
    Ann Rheum Dis; 2004 Apr; 63(4):469-70. PubMed ID: 15020353
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnosis and therapy of peripheral disorders of the blood circulation with special consideration of the effect of beta pyridyl carbinol].
    Broghammer H
    Med Welt; 1967 Apr; 17():1091-100. PubMed ID: 5586962
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of clinical testing of a circulatory geriatric agent with vitamins].
    Bense K; Schwarz A
    Landarzt; 1967 Dec; 43(34):1690-1. PubMed ID: 5610818
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of venous disorders in women].
    Delacroix P
    Sem Hop; 1980 Oct 18-25; 56(39-40):1599-601. PubMed ID: 6255576
    [No Abstract]   [Full Text] [Related]  

  • 59. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
    Hild R
    Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
    [No Abstract]   [Full Text] [Related]  

  • 60. [L.M. 192 in ophthalmologic therapy].
    Déodati F; Labro JB; Arné JL
    Bull Soc Ophtalmol Fr; 1972; 72(7):763. PubMed ID: 4661347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.